Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Polymyxins retain in vitro activity and in vivo efficacy against “resistant” Acinetobacter baumannii strains when tested in physiological conditions

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00725-24Source: DataRank Database

Polymyxins retain in vitro activity and in vivo efficacy against “resistant” Acinetobacter baumannii strains when tested in physiological conditions is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.83)OA: hybridTopics (53)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jun Yan ORCID,Sarah Miller ORCID,Jiaqi Cheng ORCID,Rachel Li ORCID,Zac Builta

Live enrichment

PubMed:39240097 PMC:PMC11459914 OpenAlex:https://openalex.org/W4402312053

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI139052

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: 2RO1AI130060

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: RO1AI179046

MOHW | Food and Drug Administration

Grant: 75F40122C00138

NIEHS NIH HHS

Grant: 27302C0138

NIAID NIH HHS

Grant: R01 AI179046

NIAID NIH HHS

Grant: R01 AI130060

National Institutes of Health

Grant: 5R01AI130060-04

MAb Passive Vaccination against Acinetobacter baumannii

National Institutes of Health

Grant: 5R01AI139052-02

Characterization of Rifabutin Therapy Against Antibiotic-Resistant Bacteria

National Institutes of Health

Grant: 1R01AI179046-01A1

Identifying Synergistic Rifabutin-Containing Combinations Against A. baumannii

FWCI

0.83

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.00725-24

publisherhttps://doi.org/10.1128/aac.00725-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00725-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39240097

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11459914

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPharmaceutical and Antibiotic Environmental Impacts0301 basic medicine03 medical and health sciencesAcinetobacter baumanniiMicrobial Sensitivity TestsAnti-Bacterial AgentsMiceAnimalsPolymyxinsAcinetobacter InfectionsColistinPolymyxin BDrug Resistance, Multiple, BacterialHumansDrug Resistance, Bacterial

MeSH Terms

Acinetobacter InfectionsAnimalsAnti-Bacterial AgentsColistinHumansMicrobial Sensitivity TestsPolymyxin BPolymyxinsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialAcinetobacter baumanniiMice

Keywords

PolymyxinColistinAcinetobacter baumanniiMicrobiologyPolymyxin BIn vivoBiologyAntibioticsAcinetobacterMinimum inhibitory concentrationBacteriaPseudomonas aeruginosaBiotechnologyAntibiotic ResistancePolymyxinsMicrobial Sensitivity TestsAnti-Bacterial AgentsMiceMechanisms of ResistanceDrug Resistance, Multiple, BacterialDrug Resistance, BacterialAnimalsHumansAcinetobacter Infections

Sustainable Development Goals

SDG 0: Good health and well-being